An acknowledged knowledgeable in Neuroradiology, Musculoskeletal Radiology, and Interventional Radiology, Dr. Bravo brings greater than 30 years of broad expertise to Calyx. His experience stems from having served as a board-certified diagnostic radiologist at extremely acclaimed healthcare facilities together with Brigham and Ladies’s Hospital, as a college member at main tutorial establishments resembling Harvard Medical College, and as a trusted scientific advisor to quite a few international pharmaceutical corporations. Previous to becoming a member of Calyx, he was the Medical Director of Sand Lake Imaging, on the Worldwide Scientific Advisory Board for Siemens Medical Company’s syngo.through, and served as an investigator on over 100 pharmaceutical, non-pharmaceutical, and government-funded analysis initiatives.
“As one of many trade’s key opinion leaders and a working towards radiologist, Dr. Bravo brings a well-rounded and strategic perspective on the right way to optimize scientific analysis so as to assist trial sponsors and CROs meet their improvement targets,” stated Gavin Nichols, CEO of Calyx. “We’re thrilled to have him be part of us – and know that our clients will profit from the deep and numerous expertise he brings to the desk.”
As CMO, Dr. Bravo will lead the corporate’s scientific, medical, and scientific teams in evolving the Calyx reader mannequin and in defining options and companies that meet the wants of Calyx clients at the moment and because the discipline of scientific analysis continues to evolve.
“The gathering, administration, evaluation, and submission of scientific trial knowledge presents quite a few challenges for scientific researchers,” stated Dr. Bravo. “Because the chief in delivering modern imaging and eClinical options, Calyx has set the usual for reliably fixing advanced issues to assist the worldwide scientific analysis group succeed. I am excited to work with our group of 80 in-house scientific, medical, and scientific specialists in advancing scientific improvement for our international clients.”
Click here for extra data on the companies delivered by Calyx’s scientific, medical, and scientific group.
Via modern eClinical options and companies, Calyx turns the unsure into the dependable, serving to convey new medical therapies to market reliably. With deep experience in scientific improvement and greater than 25 years supporting trial sponsors and scientific analysis organizations, Calyx harnesses its intelligence and expertise to resolve advanced issues, ship quick insights, and get new medication to market daily.